Filtered By:
Source: Cardiovascular Therapeutics
Condition: Hypertension
This page shows you your search results in order of date.
Order by Relevance | Date
Total 5 results found since Jan 2013.
The modifying effect of the MTHFR genotype on the association between folic acid supplementation and pulse wave velocity: Findings from the CSPPT
ConclusionIn a subgroup of Chinese hypertensive patients who had received 5 ‐year antihypertensive therapy, increases in folate status were associated with higher reductions in PWV, and individuals with the CC genotype showed greatest PWV response to folic acid supplementation.
Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Xin Yang,
Minghua Zhang,
Rensheng Song,
Changfu Liu,
Yong Huo,
Geng Qian Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Predicting long ‐term ischemic events using routine clinical parameters in patients with coronary artery disease: The OPT‐CAD risk score
ConclusionsAmong CAD patients, a risk score based on 10 baseline clinical variables performed better than the GRACE risk score in predicting long ‐term ischemic events. However, further research is needed to assess the value of the OPT‐CAD score in guiding the management of antiplatelet therapy for patients with CAD.
Source: Cardiovascular Therapeutics - September 12, 2018 Category: Cardiology Authors: Yaling Han,
Jiyan Chen,
Miaohan Qiu,
Yi Li,
Jing Li,
Yingqing Feng,
Jian Qiu,
Liang Meng,
Yihong Sun,
Guizhou Tao,
Zhaohui Wu,
Chunyu Yang,
Jincheng Guo,
Kui Pu,
Shaoliang Chen,
Xiaozeng Wang Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Clinical and Economic Outcomes among Elderly Myocardial Infarction Survivors in the United States
ConclusionsRisks of mortality and cardiovascular events remain high in a Medicare population surviving >1 year after a MI. Continuing healthcare costs are doubled over pre‐MI levels up to five years after an MI. Secondary prevention measures beyond the acute post‐MI period may be indicated to reduce risk and cost in this chronic disease phase.This article is protected by copyright. All rights reserved.
Source: Cardiovascular Therapeutics - July 31, 2016 Category: Cardiology Authors: Erru Yang, Michael Stokes, Saga Johansson, Carl Mellstr öm, Elizabeth Magnuson, David J. Cohen, Phillip Hunt Tags: Original Research Article Source Type: research
